Menu
Back to Journals » ImmunoTargets and Therapy » Volume 11 » default
ESCI
SJR OA
CiteScore
Impact Factor
ImmunoTargets and Therapy
ISSN: 2253-1556
- View all (170)
- Volume 13, 2024 (15)
- Volume 12, 2023 (14)
- Volume 11, 2022 (6)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Archive: Volume 11, 2022
Review
β-Glucan “Trained Immunity” Immunomodulatory Properties Potentiate Tissue Wound Management and Accelerate Fitness Recover
Renke G, Baesso T, Paes R, Renke A
ImmunoTargets and Therapy 2022, 11:67-73
Published Date: 17 October 2022
Review
A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects
Celik M, Fuehrlein B
ImmunoTargets and Therapy 2022, 11:55-66
Published Date: 29 September 2022
Review
The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome
Macdougall JD, Thomas KO, Iweala OI
ImmunoTargets and Therapy 2022, 11:37-54
Published Date: 15 September 2022
Review
Current Strategies in Treating Cytokine Release Syndrome Triggered by Coronavirus SARS-CoV-2
Wang LG, Wang L
ImmunoTargets and Therapy 2022, 11:23-35
Published Date: 18 May 2022
Review
Immunotargets and Therapy for Prurigo Nodularis
Labib A, Ju T, Vander Does A, Yosipovitch G
ImmunoTargets and Therapy 2022, 11:11-21
Published Date: 26 April 2022
Review
Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma
Lin AY, Schnitter JM, Gordon LI
ImmunoTargets and Therapy 2022, 11:1-10
Published Date: 23 February 2022